Prostate |
CXCR3A |
Augment invasion and proliferation |
[46,47] |
CXCR3B |
Suppress invasion and proliferation |
[46,47] |
Melanoma |
CXCR3A |
Augment invasion and brain metastasis in vivo
|
[41,50–52] |
Colorectal |
CXCR3A |
Increased proliferation invasion, migration, lymph node and tail-vein metastasis |
[29,42,59–62] |
CXCR3B |
Inhibition of proliferation, invasion and migration |
[63] |
Breast |
CXCR3A |
Increased migration, and cardiac -injection bone metastasis |
[72, 74, 94] |
CXCR3B |
Increased Cancer Stem Cell Features and in vivo metastasis |
[65, 95] |
Ovarian |
CXCR3 |
Increased migration to malignant ascites |
[98] |
Gastric |
CXCR3A |
Increased migration, invasion, and liver metastases |
[28, 102] |
Hepatocellular Carcinoma |
CXCR3 |
Increased invasion, migration, tail-vein lung metastases |
[103–105] |
Pancreatic |
CXCR3A |
Increased invasion |
[36,37] |
Lung |
CXCR3 |
Stimulate migration |
[125] |
Renal Cell Carcinoma |
CXCR3A |
Induced migration |
[32] |
CXCR3B |
Suppressed proliferation Increased Apoptosis |
[24,129] |